RESUMO
Newborn screening (NBS) of cystic fibrosis (CF) was implemented throughout the whole of France in 2002, but it had been established earlier in three western French regions. It can reveal atypical CF with one or two known CFTR mild mutations, with an uncertain evolution. The sweat test can be normal or borderline. In Brittany, from 1989 to 2004, 196 CF cases were diagnosed (1/2885 births). The incidence of atypical CF diagnosed by NBS is 9.7% (19 from 196). The outcome of 17 (2 lost of view) has been studied, with 9 other atypical CF cases diagnosed by NBS in two other regions. The follow-up period extends from 0.25 to 19.8 years (NBS implemented in Normandy in 1980) with mean age 4.6 years. The most frequent mild mutation is R117H ISV8-7T (50%). At the time of the last visit, nutritional status is normal. All these CF patients are pancreatic sufficient. Only one patient exhibits respiratory infections, whereas 7 others have them intermittently. Two of them had intermittent Pseudomonas aeruginosa colonization at 2.8 and 6.5 years. Mean Shwachman score is 96.7, mean Brasfield score is 22.8. Eight children have had lung function tests (mean follow-up of 10 years): mean FVC was 99% of predicted, mean FEV1 101%, but one of them has FEV1 of 48%. Predicting the phenotype of these atypical CF patients remains difficult, thus complicating any genetic counselling. A regular clinical evaluation is necessary, if possible by a CF unit, because CF symptoms may appear later.
Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/sangue , Fibrose Cística/diagnóstico , Fibrose Cística/genética , Mutação , Triagem Neonatal/métodos , Adolescente , Criança , Pré-Escolar , Fibrose Cística/complicações , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Valor Preditivo dos Testes , Infecções por Pseudomonas/complicações , Reprodutibilidade dos TestesRESUMO
We report the association of CDH1/E-cadherin mutations with cleft lip, with or without cleft palate (CLP), in two families with hereditary diffuse gastric cancer (HDGC). In each family, the CDH1 mutation was a splicing mutation generating aberrant transcripts with an in-frame deletion, removing the extracellular cadherin repeat domains involved in cell-cell adhesion. Such transcripts might encode mutant proteins with trans-dominant negative effects. We found that CDH1 is highly expressed at 4 and 5 weeks in the frontonasal prominence, and at 6 weeks in the lateral and medial nasal prominences of human embryos, and is therefore expressed during the critical stages of lip and palate development. These findings suggest that alteration of the E-cadherin pathway can contribute to human clefting.
Assuntos
Caderinas/genética , Fenda Labial/genética , Fissura Palatina/genética , Mutação/genética , Neoplasias Gástricas/genética , Adulto , Análise Mutacional de DNA , Perfilação da Expressão Gênica , Humanos , LinhagemAssuntos
Fibrose Cística/diagnóstico , Fibrose Cística/genética , Mutação , Triagem Neonatal/ética , França , Humanos , Recém-NascidoAssuntos
Fibrose Cística/diagnóstico por imagem , Ultrassonografia Pré-Natal , Fibrose Cística/diagnóstico , Fibrose Cística/epidemiologia , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Feminino , França/epidemiologia , Heterozigoto , Humanos , Incidência , Intestinos/diagnóstico por imagem , Mutação , Gravidez , Resultado da Gravidez , Estudos Retrospectivos , Fatores de Risco , Ultrassonografia Pré-Natal/métodosAssuntos
Processamento Alternativo/genética , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/genética , Deleção de Sequência/genética , Alelos , Fibrose Cística/patologia , DNA/química , DNA/genética , Análise Mutacional de DNA , Europa (Continente) , Feminino , Genótipo , Haplótipos , Homozigoto , Humanos , Masculino , Fenótipo , Mutação Puntual , Índice de Gravidade de DoençaRESUMO
Over a 12-month period, we diagnosed poorly differentiated infiltrative independent-cell gastric adenocarcinoma in two brothers and one sister aged 41 to 47 years. Their father had died from antral cancer at the age of 34 years. These cancers had two characteristic clinical features: rapid course and distant malignant dissemination. In all three patients, polymerase chain reaction-sequencing of the E-cadherin (CDH1) gene of white blood cells identified a heterozygous nonsense mutation of exon 3, producing a stop codon at position 95 (Q95X), resulting in a truncated protein. The alteration of this protein, which plays a crucial role in epithelial cell adhesion, probably explains the clinical expression in this type of familial diffuse gastric cancer.
Assuntos
Caderinas/genética , Linite Plástica/diagnóstico , Linite Plástica/genética , Mutação , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/genética , Adulto , Endossonografia , Evolução Fatal , Feminino , Seguimentos , Gastrectomia , Mucosa Gástrica/patologia , Marcadores Genéticos/genética , Humanos , Linite Plástica/cirurgia , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica , Linhagem , Neoplasias Gástricas/cirurgia , Resultado do TratamentoRESUMO
Many studies have shown that congenital absence of the vas deferens (CAVD) is a genital cystic fibrosis transmembrane conductance regulator (CFTR)-mediated phenotype, with a broad spectrum of abnormalities causing male infertility. The genotype of these patients includes mutations in the CFTR gene, e.g. DeltaDeltaF508, R117H and the T5 allele; all of which are commonly found in CAVD. In this study we have screened the entirety of CFTR gene in 47 males with anomalies of the vas deferens: 37 cases of congenital bilateral absence of the vas deferens, three cases of congenital unilateral absence of the vas deferens and seven cases of obstructive azoospermia with hypoplastic vas deferens. Among the 94 chromosomes studied, 65 mutations, of which three are novel (2789+2insA, L1227S, 4428insGA), were identified. The majority of patients (63.8%) had two detectable CFTR gene mutations. Furthermore, high frequencies of the DeltaDeltaF508 mutation (44.7%), the T5 allele (36.2%) and R117H mutation (19.1%) were observed.
Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Mutação , Ducto Deferente/anormalidades , Adulto , Alelos , Estudos de Coortes , Testes Genéticos , Humanos , Masculino , Oligospermia/genéticaRESUMO
We have collated the results of cystic fibrosis (CF) mutation analysis conducted in 19 laboratories in France. We have analyzed 7, 420 CF alleles, demonstrating a total of 310 different mutations including 24 not reported previously, accounting for 93.56% of CF genes. The most common were F508del (67.18%; range 61-80), G542X (2.86%; range 1-6.7%), N1303K (2.10%; range 0.75-4.6%), and 1717-1G>A (1.31%; range 0-2.8%). Only 11 mutations had relative frequencies >0. 4%, 140 mutations were found on a small number of CF alleles (from 29 to two), and 154 were unique. These data show a clear geographical and/or ethnic variation in the distribution of the most common CF mutations. This spectrum of CF mutations, the largest ever reported in one country, has generated 481 different genotypes. We also investigated a cohort of 800 French men with congenital bilateral absence of the vas deferens (CBAVD) and identified a total of 137 different CFTR mutations. Screening for the most common CF defects in addition to assessment for IVS8-5T allowed us to detect two mutations in 47.63% and one in 24.63% of CBAVD patients. In a subset of 327 CBAVD men who were more extensively investigated through the scanning of coding/flanking sequences, 516 of 654 (78. 90%) alleles were identified, with 15.90% and 70.95% of patients carrying one or two mutations, respectively, and only 13.15% without any detectable CFTR abnormality. The distribution of genotypes, classified according to the expected effect of their mutations on CFTR protein, clearly differed between both populations. CF patients had two severe mutations (87.77%) or one severe and one mild/variable mutation (11.33%), whereas CBAVD men had either a severe and a mild/variable (87.89%) or two mild/variable (11.57%) mutations.
Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/epidemiologia , Fibrose Cística/genética , Mutação/genética , Ducto Deferente/anormalidades , Adulto , Alelos , Deleção Cromossômica , Mutação da Fase de Leitura/genética , França/epidemiologia , Frequência do Gene , Genótipo , Humanos , Infertilidade Masculina/epidemiologia , Infertilidade Masculina/genética , Masculino , Pessoa de Meia-Idade , Mutagênese Insercional/genética , Mutação de Sentido Incorreto/genética , Polimorfismo Genético/genéticaRESUMO
Congenital bilateral absence of the vas deferens (CBAVD) is found in most males with cystic fibrosis (CF), but this malformation can be observed without any pulmonary or digestive features. We have analyzed 13 exons of the CF gene in a cohort of 25 CBAVD patients. Among the 50 chromosomes studied, 24 mutations were identified: delta F508 (14 cases), R117H (7 cases), R1070W (2 cases), 621 + 1 G --> T (1 case), and A1067V (1 case). Except for delta F508, the most frequent mutations (R117H, R1070W) were not observed in the CF group (109 patients) studied in our laboratory. We discuss the significance of these results.
Assuntos
Fibrose Cística/genética , Proteínas de Membrana/genética , Ducto Deferente/anormalidades , Adulto , Sequência de Bases , Regulador de Condutância Transmembrana em Fibrose Cística , DNA/análise , DNA/química , Éxons , Deleção de Genes , Genótipo , Humanos , Masculino , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Mutação , Reação em Cadeia da Polimerase , Splicing de RNARESUMO
Two groups of infertile men with obstructive azoospermia were screened for cystic fibrosis (CF) gene mutations (delta F508, exons 3, 4, 7, 10, 11, 14a, 17b, 19, 20, 21). The first group was composed of 26 patients with congenital agenesis of vas deferens (CAVD). The second group was composed of 12 patients with obstructive azoospermia associated with chronic suppurating respiratory disease (Young's syndrome). Of the group with CAVD, 77% of patients showed at least one mutation in the CF transmembrane conductance regulator (CFTR) gene. The delta F508 mutation occurred most frequently (54%), and the second most frequent mutation to occur was R117H (27%). Six patients were double heterozygotes. In Young's syndrome, no CF mutations were detected. CAVD can be considered as an incomplete clinical form of CF. However, the differences observed in CF mutations between CF and CAVD suggest that they are different disorders resulting from mutations in the same gene. Young's syndrome is a very different clinical entity.
Assuntos
Bronquiectasia/complicações , Proteínas de Membrana/genética , Mutação , Oligospermia/complicações , Oligospermia/genética , Ducto Deferente/anormalidades , Adulto , Fibrose Cística/metabolismo , Regulador de Condutância Transmembrana em Fibrose Cística , Humanos , Masculino , SíndromeRESUMO
The authors describe a cystic fibrosis family genotype analysis showing that the R297Q amino acid change is a rare polymorphism rather than a deleterious mutation as previously reported. Indeed in this family two healthy subjects have the following genotypes: delta F508/R297Q and N1303K/R297Q.
Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/genética , Polimorfismo Genético , Adulto , Feminino , Genótipo , Humanos , Masculino , Mutação , LinhagemRESUMO
Haemochromatosis is an inherited disorder of iron metabolism characterized by a general iron over loading. Without diagnosis and early treatment, it is a serous and potentially fatal disease by cardiac failure or hepatocellular carcinoma in particular. Gene prevalence was estimated at 0.06 in Brittany, so that haemochromatosis may be the most common genetic disease in this area. The biochemical defect of the disease is unknown; only one fact is well established: the iron absorption through duodenal mucosa is excessive. However, we don't know if it is a primary event. The gene is also unknown but in 1975 it was located on the short arm of chromosome 6, closely linked to the HLA class I region, less than 1 cM from HLA-A. None of the genes coding for the known iron proteins could be the haemochromatosis gene because of their chromosomal localization. In order to locate this gene with precision, we have used a reverse genetic approach now called positional cloning. Characterization of new polymorphic markers and linkage disequilibrium analysis have led us to locate the gene within a 350 kb region around HLA-A. We have then searched for all the structural genes in this region. Seven new genes have been so identified and located with precision. A structural analysis of these genes was undertaken to find an eventual abnormality in patients.
Assuntos
Hemocromatose/genética , Inversão Cromossômica , Mapeamento Cromossômico , Clonagem Molecular/métodos , Frequência do Gene , Triagem de Portadores Genéticos , Antígenos HLA/genética , Antígeno HLA-A1/genética , Hemocromatose/epidemiologia , Hemocromatose/metabolismo , Antígenos de Histocompatibilidade Classe I/genética , Humanos , Desequilíbrio de Ligação , Biologia Molecular , Reação em Cadeia da Polimerase , Polimorfismo Genético , Antígenos HLA-ERESUMO
Haemochromatosis is an inherited disorder of iron metabolism characterized by a general iron over loading. Without diagnosis and early treatment, it is a serious and potentially fatal disease by cardiac failure or hepatocellular carcinoma in particular. Gene prevalence was estimated at 0.06 in Brittany, so that haemochromatosis may be the most common genetic disease in this area. The biochemical defect of the disease is unknown; only one fact is well established: the iron absorption through duodenal mucosa is excessive. However we don't know if it is a primary event. The gene is also unknown but in 1975 it was located on the short arm of chromosome 6, closely linked to the HLA class I region, less than 1 cM from HLA-A. None of the genes coding for the known iron proteins could be the haemochromatosis gene because of their chromosomal localization. In order to locate this gene with precision, we have used a reverse genetic approach now called positional cloning. Characterization of new polymorphic markers and linkage disequilibrium analysis, have led us to locate the gene within a 350 kb region around HLA-A. We have then searched for all the structural genes in this region. Seven new genes have been so identified and located with precision. A structural analysis of these genes was undertaken to find an eventual abnormality in patients.
Assuntos
Hemocromatose/genética , HumanosRESUMO
Perhexiline is a lysosomotropic agent which has proved to be very valuable to certain patients suffering from angina pectoris. However long-term administration of the drug may induce hepato- and neuro-toxicity. Using HTC cells (a rat hepatoma-derived cell line) whose plasma membranes were labeled with NaB[3H]4 after oxidation by NaIO4, endocytosis and recycling of labeled asialo-orosomucoid (ASOR) receptors were investigated in the presence of 50 mumols/l perhexiline maleate. The results demonstrate that the drug induces a significant decrease of the rate of both the internalization and the recycling of ASOR receptors. The mechanisms responsible for these effects have not yet been elucidated. However, the current findings may be related to the previously observed inhibitory effect of perhexiline on cellular (Na+, K+)-ATPase and Mg++-ATPase activities. Our findings would then reflect insufficient cellular energy production, resulting from depressed ATP hydrolysis in the presence of perhexiline.
Assuntos
Endocitose/efeitos dos fármacos , Perexilina/farmacologia , Receptores Imunológicos/metabolismo , Animais , Receptor de Asialoglicoproteína , Células Cultivadas , Cinética , Neuraminidase/farmacologia , Orosomucoide/metabolismo , Ratos , Receptores Imunológicos/efeitos dos fármacosAssuntos
Líquido Amniótico/enzimologia , Fibrose Cística/diagnóstico , Doenças Fetais/diagnóstico , Diagnóstico Pré-Natal , Fosfatase Alcalina/análise , Aminopeptidases/análise , Antígenos CD13 , Feminino , Doenças Fetais/enzimologia , Humanos , Isoenzimas/análise , Leucil Aminopeptidase/análise , Gravidez , gama-Glutamiltransferase/análiseRESUMO
Primary cancer of the liver, especially common in inter-tropical Africa and South-East Asia, still remains inaccessible to a really effective therapy, except for a rapid surgical excision. Improvement of its particularly poor prognosis requires therefore early screening based on reliable biological markers. Following alpha-feto-protein, various parameters have been proposed: enzyme, ferritin, desialylated serum protein, decarboxylated prothrombin... However, alpha-feto-protein remains, in practice, the reference diagnostic test, in spite of a moderate specificity below 500 ng/ml and the fact that it is frequently missing in early cancers. Its diagnostic score may be improved either by the use of monoclonal antibodies, or by determining the ratio of fucosylated form, or by concomitant use of other markers: alpha-L-fucosidase, decarboxy-prothrombin.